查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
蛋白质体学市场 - 全球和区域分析：按产品、应用、最终用户和区域 - 分析和预测（2024-2034 年）
市场调查报告书
商品编码
1671814

蛋白质体学市场 - 全球和区域分析：按产品、应用、最终用户和区域 - 分析和预测（2024-2034 年）

Proteomics Market - A Global and Regional Analysis: Focus on Offerings, Application, End User, and Region - Analysis and Forecast, 2024-2034
出版日期: | 出版商: BIS Research | 英文 176 Pages | 商品交期: 1-5个工作天内

价格

全球蛋白质体学市场规模预计将从 2024 年的 339.2 亿美元增至 2034 年的 1,097.1 亿美元，2024-2034 年预测期内的复合年增长率为 12.46%。

推动这一成长的关键因素包括质谱和次世代定序技术的进步，这些技术提高了蛋白质体学分析的准确性。

个人化医疗的需求不断增长，特别是生物标记的发现和疾病分析，也是一个主要驱动因素。此外，增加研究资金、策略合作以及对疾病早期发现和有效诊断的需求进一步推动了市场扩张。人口老化和慢性病的增加将继续增加医疗保健和研究对蛋白质体学的需求，推动市场持续成长。

主要市场统计数据
预测期 2024-2034
2024 年评估 339.2亿美元
2034 年预测 1097.1亿美元
复合年增长率 12.46％

全球蛋白质体学市场由几个主要部分组成，包括蛋白质分析的基本技术和工具，例如质谱、蛋白质微阵列和次世代定序。应用多种多样，包括药物发现、生物标记识别、疾病诊断和个人化医疗，所有这些都可以从蛋白质组学见解中受益。研究试剂和消耗品（包括套件和化学品）支持产业研究和实验需求。最终用户包括学术和研究机构、製药和生物技术公司、医院和诊断实验室，他们都在研究、开发和临床应用中利用蛋白质体学。从地理上看，市场正在北美、欧洲、亚太、拉丁美洲以及中东和非洲等地区扩张，其中亚太地区由于对医疗保健和生物技术的投资增加而经历快速增长。这些因素共同推动了全球蛋白质体学市场的持续发展和成长。

蛋白质体学大大提高了我们对多种疾病背后的分子机制的理解，包括癌症、心血管疾病和神经系统疾病。透过识别在疾病进展中发挥关键作用的蛋白质，蛋白质体学可以实现更有针对性和更有效的研究。

蛋白质体学促进了发现用于疾病早期检测、诊断和预测的新型生物标记。这将带来更准确、非侵入性的诊断方法，并透过早期疗育改善患者的治疗效果。

蛋白质体学的应用有助于个人化医疗的发展。透过分析蛋白质谱，可以根据每位患者的具体需求制定治疗方案，确保更有效的治疗和更少的副作用。

在药物研发中，蛋白质体学透过研究蛋白质与潜在治疗化合物的相互作用来帮助识别新的药物标靶。这将加速新药和治疗方法的开发，特别是在肿瘤学和自体免疫领域。

它透过实现更好的疾病监测、治疗效果评估和治疗计划改善了临床应用。蛋白质体学已成为临床研究和诊断平台开发的关键。

蛋白质体学的需求推动了质谱和蛋白质阵列等分析技术的重大进步。这些创新不仅有益于蛋白质体学研究，而且还延伸到其他科学学科，产生更广泛的技术影响。

本报告研究了全球蛋白质体学市场，并概述了市场状况以及产品、应用、最终用户和地区的趋势，以及参与市场的公司概况。

目录

执行摘要

第一章 市场

  • 市场展望
  • 主要发现
  • 蛋白质体学市场前景
  • 产业展望
  • 趋势：当前和未来的影响评估
  • 专利分析
  • 法律规范
  • 产品基准
  • 市场动态概览

2. 全球蛋白质体学市场（依产品分类），百万美元，2022-2034 年

  • 产品
    • 套件和试剂
    • 装置
    • 软体
  • 服务

3. 全球蛋白质体学市场（按应用），百万美元，2022-2034 年

  • 药物研发
  • 临床诊断
    • 癌症
    • 感染疾病
    • 其他的
  • 其他的

4. 全球蛋白质体学市场（按最终用户划分），百万美元，2022-2034 年

  • 生物製药公司
  • 学术研究所
  • 医院和诊断实验室
  • 其他的

5. 全球蛋白质体学市场（按地区划分），百万美元，2022-2034 年

  • 区域概况
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

6. 全球蛋白质体学NGS市场

  • 蛋白质体学中的NGS
  • 市场规模及预测

7. 市场竞争基准化分析和公司概况

  • 全球蛋白质体学市场：竞争格局
  • 公司简介
    • Agilent Technologies, Inc.
    • Applied Biomics
    • Biognosys AG
    • Bio-Rad Laboratories, Inc.
    • Danaher Corporation
    • DiaSorin SpA
    • Illumina, Inc.
    • Merck KGaA
    • MS Bioworks
    • Promega Corporation
    • Oxford Expression Technologies Ltd.
    • Revvity, Inc.
    • Standard BioTools Inc.
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.

第 8 章调查方法

Product Code: BHP1781SA

Introduction to Proteomics Market

The global proteomics market is projected to reach $109.71 billion by 2034 from $33.92 billion in 2024, growing at a CAGR of 12.46% during the forecast period 2024-2034. Key factors driving this growth include technological advancements in mass spectrometry and next-generation sequencing, which improve the accuracy of proteomics analysis.

The rising demand for personalized medicine, particularly for biomarker discovery and disease profiling, is another major driver. Additionally, increased research funding, strategic collaborations, and the need for early disease detection and effective diagnostics further support market expansion. With an aging population and a higher prevalence of chronic diseases, the demand for proteomics in healthcare and research is expected to continue to rise, ensuring the market's sustained growth.

KEY MARKET STATISTICS
Forecast Period2024 - 2034
2024 Evaluation$33.92 Billion
2034 Forecast$109.71 Billion
CAGR12.46%

Market Introduction

The global proteomics market consists of several key segments, including technologies and tools such as mass spectrometry, protein microarrays, and next-generation sequencing, which are essential for protein analysis. Applications span across drug discovery, biomarker identification, disease diagnostics, and personalized medicine, all of which benefit from proteomics insights. Reagents and consumables, including kits and chemicals, support the research and experimental needs of the industry. End users include academic and research institutes, pharmaceutical and biotechnology companies, hospitals, and diagnostic labs, all leveraging proteomics for research, development, and clinical applications. Geographically, the market is expanding in regions such as North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa, with Asia-Pacific experiencing rapid growth due to increasing investments in healthcare and biotechnology. Together, these elements drive the continued evolution and growth of the proteomics market globally.

Impact Analysis:

The proteomics market has made an impact in the following ways:

  • Advancement of Disease Understanding: Proteomics has greatly improved our understanding of the molecular mechanisms behind various diseases, including cancer, cardiovascular diseases, and neurological disorders. By identifying proteins that play critical roles in disease progression, proteomics enables more targeted and effective research.
  • Biomarker Discovery for Diagnostics: Proteomics has facilitated the discovery of novel biomarkers for early detection, diagnosis, and prognosis of diseases. This has led to more precise and non-invasive diagnostic methods, improving patient outcomes through early intervention.
  • Personalized Medicine: The application of proteomics has been instrumental in the development of personalized medicine. By analyzing protein profiles, treatments can be tailored to the specific needs of individual patients, ensuring more effective therapies with fewer side effects.
  • Drug Development and Target Identification: In drug discovery, proteomics helps in identifying new drug targets by studying the interactions between proteins and potential therapeutic compounds. This accelerates the development of new drugs and treatments, particularly in the oncology and autoimmune sectors.
  • Improvement in Clinical Applications: Proteomics has enhanced clinical applications by enabling better disease monitoring, therapeutic efficacy assessments, and treatment planning. It has become an integral part of clinical research and the development of diagnostic platforms.
  • Technological Innovation: The demand for proteomics has driven significant advancements in analytical technologies, such as mass spectrometry and protein arrays. These innovations not only benefit proteomics research but also spill over into other scientific fields, creating broader technological impacts.

Market Segmentation:

Segmentation 1: by Offering

  • Product
  • Service

Product Segment to Continue Dominating the Proteomics Market (by Offering)

Based on offering, the proteomics market is led by product, which held a 72.53% share in 2022.

Segmentation 2: by Application

  • Drug Discovery
  • Clinical Diagnostics
  • Others

Drug Discovery Segment to Continue Dominating the Proteomics Market (by Application)

Based on application, the proteomics market is led by drug discovery, which held a 53.64% share in 2022.

Segmentation 3: by End User

  • Biopharmaceutical Companies
  • Academic and Research Institutions
  • Hospitals and Diagnostic Laboratories
  • Others

Academic and Research Institutions Segment to Continue Holding its Dominance in the Proteomics Market (by End User)

Based on end user, the proteomics market is led by academic and research institutions, which held a 51.50% share in 2022.

Segmentation 4: by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest-of-Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest-of-Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest-of-Latin America
  • Middle East and Africa

China dominated the Asia-Pacific proteomics market in 2022, driven by several key factors. The country has made substantial investments in healthcare, biotechnology, and life sciences research, positioning itself as a leader in the region. China's robust infrastructure, large population, and government initiatives, such as the ""Made in China 2025"" plan, which emphasizes technological innovation, have further accelerated advancements in proteomics technologies.

In addition, China has become a hub for pharmaceutical and biotechnology companies, fostering an environment conducive to research and development in areas such as drug discovery, personalized medicine, and biomarker identification. The growing demand for proteomics in clinical diagnostics, coupled with the country's increasing focus on precision medicine, has bolstered market growth.

Moreover, the rapid adoption of advanced proteomics technologies, such as mass spectrometry and next-generation sequencing, has allowed China to expand its research capabilities and enhance its position in the global market. With a strong emphasis on improving healthcare outcomes and expanding its scientific capabilities, China is expected to continue to lead the proteomics market in the Asia-Pacific region for the foreseeable future.

Recent Developments in the Proteomics Market

  • In November 2024, Seer, Inc. announced that it had entered into a co-marketing and sales agreement with Thermo Fisher Scientific Inc., the global leader in serving science, to jointly promote Seer's Proteograph Product Suite alongside Thermo Fisher Scientific Inc. Orbitrap Astral mass spectrometers. This strategic collaboration was designed to accelerate the adoption of advanced proteomic technologies, providing researchers with an integrated solution for deep, rapid, and unbiased proteomic analysis at scale.
  • In November 2024, Sengenics Corporation LLC was acquired by Standard BioTools Inc..
  • In October 2024, SCIEX, a subsidiary of Danaher Corporation, announced three strategic collaborations to enhance key proteomics capabilities further. The ZenoTOF 7600+ system was made compatible with PEAKS 12.5 from Bioinformatics Solutions Inc., the Evosep One from Evosep, and the Aurora Series XS Range from IonOpticks.
  • In July 2024, Thermo Fisher Scientific Inc. finalized its acquisition of Olink Holding AB, a leading provider of next-generation proteomics solutions. The transaction, valued at approximately $3.1 billion, integrates Olink into Thermo Fisher Scientific Inc.'s Life Sciences Solutions segment.
  • In November 2024, Standard BioTools Inc. announced the addition of KREX precision antibody profiling services and kits to its SomaScan suite of solutions. This expanded offering enabled the detection of autoantibody biomarkers and protein interactions for basic, translational, and clinical research.
  • In October 2024, SCIEX, a subsidiary of Danaher Corporation, expanded its high-resolution accurate mass spectrometry portfolio with the launch of the ZenoTOF 7600+ system, alongside three new collaborations aimed at advancing proteomics capabilities.

Demand - Drivers and Limitations

Market Demand Drivers:

Increasing Prevalence of Chronic Diseases: The increasing global prevalence of chronic diseases, including cancer, cardiovascular diseases, and neurological disorders, is a significant driver for the proteomics market. Proteomics, with its ability to study the complete protein profile of biological systems, provides unparalleled insights into disease mechanisms, biomarker discovery, and precision medicine.

Recent breakthroughs, such as the development of proteomic tools such as aging clocks and early cancer detection tests, demonstrate the transformative potential of this technology. For instance, studies have shown proteomics-based approaches outperform traditional diagnostics, offering greater accuracy and sensitivity in detecting diseases at early stages. Moreover, advancements in top-down proteomics are bridging the gap between genotypes and phenotypes, enhancing the understanding of proteoforms and their role in disease progression.

The need for early detection, personalized treatment, and disease monitoring is fuelling investments in proteomics technologies, such as mass spectrometry and bioinformatics platforms. These innovations not only address critical healthcare challenges but also present substantial growth opportunities for companies providing proteomics solutions, making it a cornerstone for advancements in healthcare and life sciences.

Advancements in Personalized Medicine and Drug Discovery: Advancements in personalized medicine and drug discovery are significant drivers for the proteomics market, as they demand deeper insights into protein structures, functions, and interactions. Proteomics enables the identification of disease-specific biomarkers and therapeutic targets, which are critical for developing tailored treatments and accelerating drug discovery pipelines.

In personalized medicine, proteomics facilitates early disease detection, patient stratification, and real-time monitoring of treatment responses, aligning with the growing emphasis on precision healthcare. Similarly, in drug discovery, proteomics supports target validation, mechanism-of-action studies, and the evaluation of drug efficacy, helping to streamline R&D processes and reduce time-to-market for new therapies.

With rising investments in biopharmaceutical research and increasing reliance on high-throughput proteomic technologies such as mass spectrometry and bioinformatics, the proteomics market is positioned for robust growth. These advancements are not only transforming healthcare delivery but also creating substantial opportunities for companies offering innovative proteomic solutions and services.

Market Restraints:

Shortage of Skilled Professionals: The workforce shortage in proteomics highlights a critical need for industry-wide strategies to address both immediate and long-term challenges. While automation and outsourcing offer viable solutions, building a robust, well-trained workforce remains essential for sustaining growth in the proteomics market. Companies that proactively invest in talent development, employee well-being, and technology integration will be better positioned to navigate these challenges and capitalize on the growing demand for proteomics solutions.

Complexity in Analysing Data of Proteomics Research: The complexity of analyzing proteomics research data acts as a significant restraint for the proteomics market due to several challenges it imposes. Proteomics generates vast and multidimensional datasets that require specialized computational tools, advanced bioinformatics expertise, and significant processing power. The lack of standardization in data handling and interpretation further complicates reproducibility and cross-study comparisons.

For many smaller research institutions and organizations, the high costs associated with acquiring and maintaining the necessary infrastructure and the steep learning curve for using advanced analytics tools limit accessibility to proteomics research. Additionally, the scarcity of skilled professionals capable of managing and interpreting such complex datasets exacerbates this issue, creating bottlenecks in research workflows.

This restraint slows the adoption of proteomics technologies, delays the pace of discoveries, and increases the overall cost and time involved in biomarker identification, drug development, and clinical applications, thereby impeding full-scale market growth.

Market Opportunities:

Progress in Nano Proteomics Platforms to Enhance and Thoroughly Analyze Natural Protein Complexes: The progress in nano proteomics platforms presents a significant opportunity for the proteomics market by addressing critical challenges in protein analysis with innovative solutions. These platforms enable ultra-sensitive detection of low-abundance proteins and offer unparalleled insights into natural protein complexes, which are vital for understanding disease mechanisms and identifying therapeutic targets.

Nano proteomics enhances biomarker discovery, drug development, and precision diagnostics by providing high-resolution analysis with minimal sample requirements and high throughput. This aligns with the increasing demand for advanced proteomics technologies to support personalized medicine, where understanding intricate protein interactions and modifications is crucial.

As industries such as pharmaceuticals, biotechnology, and diagnostics prioritize innovation, the adoption of nano proteomics platforms creates opportunities for market players to differentiate themselves. Companies investing in nano proteomics technologies can capitalize on the growing need for cutting-edge tools that facilitate breakthroughs in healthcare research, expand clinical applications, and accelerate the development of targeted therapies. This trend is poised to drive robust growth in the proteomics market and position nano proteomics as a cornerstone of future advancements in life sciences.

How can this report add value to an organization?

Product/Innovation Strategy: The global proteomics market has been extensively segmented based on various categories, such as offering, application, end user, and region. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Growth/Marketing Strategy: The new offering accounted for the maximum number of key developments in the global proteomics market between January 2022 and December 2024.

Competitive Strategy: The global proteomics market has numerous established players with product and service portfolios. Key players in the global proteomics market analyzed and profiled in the study involve established players offering proteomics products and services.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • Detailed secondary research was performed to ensure maximum coverage of manufacturers/suppliers operational in a country.
  • Exact revenue information, up to a certain extent, was extracted for each company from secondary sources and databases. The revenues specific to the offering, application, end user, and region were then estimated for each market player based on fact-based proxy indicators as well as primary inputs.
  • The scope of this report has been carefully derived based on interactions with experts in different companies across the world. This report provides a market study of proteomics.
  • The market contribution of the proteomics anticipated to be launched in the future has been calculated based on historical analysis. This analysis has been supported by proxy factors such as the innovation scale of the companies, the status of funding, collaborations, customer base, and patent scenario.
  • The scope of availability of proteomics products and services in a particular region has been assessed based on a comprehensive analysis of companies' prospects, regional end-user perception, and other factors impacting the launch of proteomics products and services in that region.
  • The base year considered for the calculation of the market size is 2023. A historical year analysis has been done for the period FY2020-FY2022. The market size has been estimated for FY2023 and projected for the period FY2024-FY2034.
  • Revenues of the companies have been referenced from their annual reports for FY2020-FY2023. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, product approval status, market collaborations, and operational history.
  • Regional distribution of the market revenue has been estimated based on the companies in each region and the adoption rate of proteomics. All the numbers have been adjusted to a single digit after the decimal for better presentation in the report. However, the real figures have been utilized for compound annual growth rate (CAGR) estimation. The CAGR has been calculated for the period 2024-2034.
  • The market has been mapped based on the available proteomics. All the key companies with significant offerings in this field have been considered and profiled in this report.
  • Market strategies and developments of key players have been considered for the calculation of the potential of the market in the forecast period.

Primary Research:

The primary sources involve industry experts in the proteomics market, including the market players offering proteomics solutions. Resources such as CXOs, vice presidents, product managers, directors, territory managers, and business development have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

  • Validation and triangulation of all the numbers and graphs
  • Validation of the report's segmentation and key qualitative findings for proteomics
  • Understanding the competitive landscape and business model
  • Current and proposed production values of a product by market players
  • Validation of the numbers of the different segments of the market in focus
  • Percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • European Medicines Agency (EMA), American Chemical Society (ACS), Frontiers, World Health Organization (WHO), and National Center for Biotechnology Information (NCBI), among others
  • Annual reports, SEC filings, and investor presentations of the leading market players
  • Company websites and detailed study of their portfolios
  • Gold standard magazines, journals, whitepapers, press releases, and news articles
  • Databases

The key data points taken from the secondary sources include:

  • Segmentation and percentage share estimates
  • Company and country understanding, and data for market value estimation
  • Key industry/market trends
  • Developments among top players
  • Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, type portfolio, and market penetration.

Some prominent names in the global proteomics market include:

  • Danaher Corporation
  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies, Inc.
  • Bio-rad Laboratories
  • Revvity, Inc.
  • Illumina, Inc.
  • DiaSorin S.p.A.
  • Takara Bio Inc.
  • Merck KGaA

Table of Contents

Executive Summary

Scope and Definition

1 Market

  • 1.1 Market Outlook
    • 1.1.1 Comparative Advantages and Disadvantages of Proteomics Over Other Omics
    • 1.1.2 Proteomics Techniques by Introduction with Principles and Advantages/Limitations
  • 1.2 Key Findings
  • 1.3 Proteomics Market Scenario
    • 1.3.1 Realistic Scenario
    • 1.3.2 Optimistic Scenario
    • 1.3.3 Pessimistic Scenario
  • 1.4 Industry Outlook
    • 1.4.1 Supply Chain Overview
  • 1.5 Trends: Current and Future Impact Assessment
    • 1.5.1 Increasing Automation for End-to-End Proteomics Workflow
    • 1.5.2 Significant Number of Collaborations among Market Players
    • 1.5.3 Growing Proteomics Research to Identify Disease Biomarkers
  • 1.6 Patent Analysis
    • 1.6.1 Patent Filing Trend (by Country, Year)
  • 1.7 Regulatory Framework
    • 1.7.1 U.S.
      • 1.7.1.1 Regulatory Requirements for Proteomics Products Intended as Medical Devices
      • 1.7.1.2 Regulatory Requirements for Research Use Only (RUO) Products
      • 1.7.1.3 Requirements under the Clinical Laboratory Improvement Amendments (CLIA) for Clinical Proteomics Labs
    • 1.7.2 European Union (EU)
      • 1.7.2.1 Regulatory Requirements for Proteomics Products Intended as Medical Devices
        • 1.7.2.1.1 EU Medical Device Regulation
        • 1.7.2.1.2 EU In Vitro Diagnostic Regulation
      • 1.7.2.2 Regulatory Requirements for Clinical Proteomics Labs in the EU
    • 1.7.3 Japan
      • 1.7.3.1 Regulatory Requirements for Proteomics Products Intended as Medical Devices
      • 1.7.3.2 Regulatory Requirements for Clinical Proteomics Labs in Japan
    • 1.7.4 China
      • 1.7.4.1 Regulatory Requirements for Proteomics Products Intended as Medical Devices
    • 1.7.5 Brazil
      • 1.7.5.1 Regulatory Requirements for Proteomics Products Intended as Medical Devices
      • 1.7.5.2 Regulatory Requirements for Clinical Proteomics Labs in Brazil
  • 1.8 Product Benchmarking
  • 1.9 Market Dynamics Overview
    • 1.9.1 Market Drivers
      • 1.9.1.1 Increasing Prevalence of Chronic Diseases
      • 1.9.1.2 Increasing Technological Advancements
      • 1.9.1.3 Advancements in Personalized Medicine and Drug Discovery
    • 1.9.2 Market Restraints
      • 1.9.2.1 Shortage of Skilled Professionals
      • 1.9.2.2 Complexity in Analyzing Data of Proteomics Research
    • 1.9.3 Market Opportunities
      • 1.9.3.1 Progress in Nanoproteomics Platforms to Enhance and Thoroughly Analyze Natural Protein Complexes

2 Global Proteomics Market (by Offering), $Million, 2022-2034

  • 2.1 Product
    • 2.1.1 Kits and Reagents
    • 2.1.2 Instruments
      • 2.1.2.1 Spectroscopy
      • 2.1.2.2 Chromatography
      • 2.1.2.3 Electrophoresis
      • 2.1.2.4 Others
    • 2.1.3 Software
  • 2.2 Service

3 Global Proteomics Market (by Application), $Million, 2022-2034

  • 3.1 Drug Discovery
  • 3.2 Clinical Diagnostics
    • 3.2.1 Cancer
    • 3.2.2 Infectious Disease
    • 3.2.3 Others
  • 3.3 Others

4 Global Proteomics Market (by End User), $Million, 2022-2034

  • 4.1 Biopharmaceutical Companies
  • 4.2 Academic and Research Institutions
  • 4.3 Hospitals and Diagnostic Laboratories
  • 4.4 Others

5 Global Proteomics Market (by Region), $Million, 2022-2034

  • 5.1 Regional Summary
  • 5.2 North America
    • 5.2.1 Regional Overview
    • 5.2.2 Driving Factors for Market Growth
    • 5.2.3 Factors Challenging the Market
    • 5.2.4 North America Proteomics Market, by Application
    • 5.2.5 North America Proteomics Market, by Offering
      • 5.2.5.1 North America Proteomics Market, by Product
    • 5.2.6 U.S.
      • 5.2.6.1 U.S. Proteomics Market, by Application
      • 5.2.6.2 U.S. Proteomics Market, by Offering
        • 5.2.6.2.1 U.S. Proteomics Market, by Product
    • 5.2.7 Canada
      • 5.2.7.1 Canada Proteomics Market, by Application
      • 5.2.7.2 Canada Proteomics Market, by Offering
      • 5.2.7.3 Canada Proteomics Market, by Product
  • 5.3 Europe
    • 5.3.1 Regional Overview
    • 5.3.2 Driving Factors for Market Growth
    • 5.3.3 Factors Challenging the Market
    • 5.3.4 Europe Proteomics Market, by Application
    • 5.3.5 Europe Proteomics Market, by Offering
      • 5.3.5.1 Europe Proteomics Market, by Product
    • 5.3.6 France
      • 5.3.6.1 France Proteomics Market, by Application
      • 5.3.6.2 France Proteomics Market, by Offering
        • 5.3.6.2.1 France Proteomics Market, by Product
    • 5.3.7 Italy
      • 5.3.7.1 Italy Proteomics Market, by Application
      • 5.3.7.2 Italy Proteomics Market, by Offering
        • 5.3.7.2.1 Italy Proteomics Market, by Product
    • 5.3.8 Germany
      • 5.3.8.1 Germany Proteomics Market, by Application
      • 5.3.8.2 Germany Proteomics Market, by Offering
        • 5.3.8.2.1 Germany Proteomics Market, by Product
    • 5.3.9 U.K.
      • 5.3.9.1 U.K. Proteomics Market, by Application
      • 5.3.9.2 U.K. Proteomics Market, by Offering
        • 5.3.9.2.1 U.K. Proteomics Market, by Product
    • 5.3.10 Spain
      • 5.3.10.1 Spain Proteomics Market, by Application
      • 5.3.10.2 Spain Proteomics Market, by Offering
        • 5.3.10.2.1 Spain Proteomics Market, by Product
    • 5.3.11 Rest-of-Europe
      • 5.3.11.1 Rest-of-Europe Proteomics Market, by Application
      • 5.3.11.2 Rest-of-Europe Proteomics Market, by Offering
        • 5.3.11.2.1 Rest-of-Europe Proteomics Market, by Product
  • 5.4 Asia-Pacific
    • 5.4.1 Regional Overview
    • 5.4.2 Driving Factors for Market Growth
    • 5.4.3 Factors Challenging the Market
    • 5.4.4 Asia-Pacific Proteomics Market, by Application
    • 5.4.5 Asia-Pacific Proteomics Market, by Offering
      • 5.4.5.1 Asia-Pacific Proteomics Market, by Product
    • 5.4.6 China
      • 5.4.6.1 China Proteomics Market, by Application
      • 5.4.6.2 China Proteomics Market, by Offering
        • 5.4.6.2.1 China Proteomics Market, by Product
    • 5.4.7 India
      • 5.4.7.1 India Proteomics Market, by Application
      • 5.4.7.2 India Proteomics Market, by Offering
        • 5.4.7.2.1 India Proteomics Market, by Product
    • 5.4.8 Australia
      • 5.4.8.1 Australia Proteomics Market, by Application
      • 5.4.8.2 Australia Proteomics Market, by Offering
        • 5.4.8.2.1 Australia Proteomics Market, by Product
    • 5.4.9 Japan
      • 5.4.9.1 Japan Proteomics Market, by Application
      • 5.4.9.2 Japan Proteomics Market, by Offering
        • 5.4.9.2.1 Japan Proteomics Market, by Product
    • 5.4.10 South Korea
      • 5.4.10.1 South Korea Proteomics Market, by Application
      • 5.4.10.2 South Korea Proteomics Market, by Offering
        • 5.4.10.2.1 South Korea Proteomics Market, by Product
    • 5.4.11 Rest-of-Asia-Pacific
      • 5.4.11.1 Rest-of-Asia-Pacific Proteomics Market, by Application
      • 5.4.11.2 Rest-of-Asia-Pacific Proteomics Market, by Offering
        • 5.4.11.2.1 Rest-of-Asia-Pacific Proteomics Market, by Product
  • 5.5 Latin America
    • 5.5.1 Regional Overview
    • 5.5.2 Driving Factors for Market Growth
    • 5.5.3 Factors Challenging the Market
    • 5.5.4 Latin America Proteomics Market, by Application
    • 5.5.5 Latin America Proteomics Market, by Offering
      • 5.5.5.1 Latin America Proteomics Market, by Product
    • 5.5.6 Brazil
      • 5.5.6.1 Brazil Proteomics Market, by Application
      • 5.5.6.2 Brazil Proteomics Market, by Offering
        • 5.5.6.2.1 Brazil Proteomics Market, by Product
    • 5.5.7 Mexico
      • 5.5.7.1 Mexico Proteomics Market, by Application
      • 5.5.7.2 Mexico Proteomics Market, by Offering
        • 5.5.7.2.1 Mexico Proteomics Market, by Product
    • 5.5.8 Rest-of-Latin America
      • 5.5.8.1 Rest-of-Latin America Proteomics Market, by Application
      • 5.5.8.2 Rest-of-Latin America Proteomics Market, by Offering
        • 5.5.8.2.1 Rest-of-Latin America Proteomics Market, by Product
  • 5.6 Middle East and Africa
    • 5.6.1 Regional Overview
    • 5.6.2 Driving Factors for Market Growth
    • 5.6.3 Factors Challenging the Market
    • 5.6.4 Middle East and Africa Proteomics Market, by Application
    • 5.6.5 Middle East and Africa Proteomics Market, by Offering
      • 5.6.5.1 Middle East and Africa Proteomics Market, by Product

6 Global NGS in Proteomics Market

  • 6.1 NGS in Proteomics
    • 6.1.1 Purpose of NGS in Proteomics
    • 6.1.2 Application of NGS in Proteomics
      • 6.1.2.1 Advantages of NGS-based Proteomics
      • 6.1.2.2 Challenges in NGS-based Proteomics
      • 6.1.2.3 Future Trends of NGS in Proteomics
    • 6.1.3 NGS in Large-Scale Proteomics
  • 6.2 Market Sizing and Forecast
    • 6.2.1 By Application
    • 6.2.2 By End User

7 Markets - Competitive Benchmarking & Company Profiles

  • 7.1 Global Proteomics Market: Competitive Landscape
    • 7.1.1 Corporate Strategies, January 2022-December 2024
    • 7.1.2 Partnerships, Alliances, and Business Expansions
    • 7.1.3 Mergers and Acquisitions
    • 7.1.4 New Offerings
  • 7.2 Company Profiles
    • 7.2.1 Agilent Technologies, Inc.
      • 7.2.1.1 Overview
      • 7.2.1.2 Top Products/Services
      • 7.2.1.3 Top Competitors
      • 7.2.1.4 Target Customers
      • 7.2.1.5 Key Personnel
      • 7.2.1.6 Analyst View
    • 7.2.2 Applied Biomics
      • 7.2.2.1 Overview
      • 7.2.2.2 Top Products/Services
      • 7.2.2.3 Top Competitors
      • 7.2.2.4 Target Customers
      • 7.2.2.5 Key Personnel
      • 7.2.2.6 Analyst View
    • 7.2.3 Biognosys AG
      • 7.2.3.1 Overview
      • 7.2.3.2 Top Products/ Services
      • 7.2.3.3 Top Competitors
      • 7.2.3.4 Target Customers
      • 7.2.3.5 Key Personnel
      • 7.2.3.6 Analyst View
    • 7.2.4 Bio-Rad Laboratories, Inc.
      • 7.2.4.1 Overview
      • 7.2.4.2 Top Products/ Services
      • 7.2.4.3 Top Competitors
      • 7.2.4.4 Target Customers
      • 7.2.4.5 Key Personnel
      • 7.2.4.6 Analyst View
    • 7.2.5 Danaher Corporation
      • 7.2.5.1 Overview
      • 7.2.5.2 Top Products/ Services
      • 7.2.5.3 Top Competitors
      • 7.2.5.4 Target Customers
      • 7.2.5.5 Key Personnel
      • 7.2.5.6 Analyst View
    • 7.2.6 DiaSorin S.p.A.
      • 7.2.6.1 Overview
      • 7.2.6.2 Top Products/ Services
      • 7.2.6.3 Top Competitors
      • 7.2.6.4 Target Customers
      • 7.2.6.5 Key Personnel
      • 7.2.6.6 Analyst View
    • 7.2.7 Illumina, Inc.
      • 7.2.7.1 Overview
      • 7.2.7.2 Top Products/ Services
      • 7.2.7.3 Top Competitors
      • 7.2.7.4 Target Customers
      • 7.2.7.5 Key Personnel
      • 7.2.7.6 Analyst View
    • 7.2.8 Merck KGaA
      • 7.2.8.1 Overview
      • 7.2.8.2 Top Products/ Services
      • 7.2.8.3 Top Competitors
      • 7.2.8.4 Target Customers
      • 7.2.8.5 Key Personnel
      • 7.2.8.6 Analyst View
    • 7.2.9 MS Bioworks
      • 7.2.9.1 Overview
      • 7.2.9.2 Top Products/Services
      • 7.2.9.3 Top Competitors
      • 7.2.9.4 Target Customers
      • 7.2.9.5 Key Personnel
      • 7.2.9.6 Analyst View
    • 7.2.10 Promega Corporation
      • 7.2.10.1 Overview
      • 7.2.10.2 Top Products/ Services
      • 7.2.10.3 Top Competitors
      • 7.2.10.4 Target Customers
      • 7.2.10.5 Key Personnel
      • 7.2.10.6 Analyst View
    • 7.2.11 Oxford Expression Technologies Ltd.
      • 7.2.11.1 Overview
      • 7.2.11.2 Top Products/ Services
      • 7.2.11.3 Top Competitors
      • 7.2.11.4 Target Customers
      • 7.2.11.5 Key Personnel
      • 7.2.11.6 Analyst View
    • 7.2.12 Revvity, Inc.
      • 7.2.12.1 Overview
      • 7.2.12.2 Top Products/ Services
      • 7.2.12.3 Top Competitors
      • 7.2.12.4 Target Customers
      • 7.2.12.5 Key Personnel
      • 7.2.12.6 Analyst View
    • 7.2.1 Standard BioTools Inc.
      • 7.2.1.1 Overview
      • 7.2.1.2 Top Products/ Services
      • 7.2.1.3 Top Competitors
      • 7.2.1.4 Target Customers
      • 7.2.1.5 Key Personnel
      • 7.2.1.6 Analyst View
    • 7.2.2 Takara Bio Inc.
      • 7.2.2.1 Overview
      • 7.2.2.2 Top Products/ Services
      • 7.2.2.3 Top Competitors
      • 7.2.2.4 Target Customers
      • 7.2.2.5 Key Personnel
      • 7.2.2.6 Analyst View
    • 7.2.3 Thermo Fisher Scientific Inc.
      • 7.2.3.1 Overview
      • 7.2.3.2 Top Products/ Services
      • 7.2.3.3 Top Competitors
      • 7.2.3.4 Target Customers
      • 7.2.3.5 Key Personnel
      • 7.2.3.6 Analyst View

8 Research Methodology

  • 8.1 Data Sources
    • 8.1.1 Primary Data Sources
    • 8.1.2 Secondary Data Sources
    • 8.1.3 Data Triangulation
  • 8.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Global Proteomics Market (by Region), $Billion, 2022, 2027, and 2034
  • Figure 2: Global Proteomics Market (by Application), $Billion, 2022, 2027, and 2034
  • Figure 3: Global Proteomics Market (by End User), $Billion, 2022, 2027, and 2034
  • Figure 4: Global Proteomics Market (by Product), $Billion, 2022, 2027, and 2034
  • Figure 5: Key Events to Keep Track of within the Proteomics Market
  • Figure 6: Global Proteomics Market Size, $Billion, 2022-2034
  • Figure 7: Proteomics Literature Published (January 2015 to December 2024)
  • Figure 8: Proteomics Market Size and Growth Potential (Realistic Scenario), $Billion, 2022-2034
  • Figure 9: Proteomics Market Size and Growth Potential (Optimistic Scenario), $Billion, 2022 to 2034
  • Figure 10: Proteomics Market Size and Growth Potential (Pessimistic Scenario), $Billion, 2022 to 2034
  • Figure 11: Supply Chain and Risks within the Supply Chain
  • Figure 12: Key Features of End-to-End Proteomics Workflow
  • Figure 13: Global Proteomics Market, Patent Analysis (by Country), January 2021-December 2024
  • Figure 14: Global Proteomics Market, Patent Analysis (by Year), January 2021-December 2024
  • Figure 15: Global Proteomics Market, Product Benchmarking (by Product)
  • Figure 16: Impact Analysis of Market Navigating Factors, 2024-2034
  • Figure 17: Timeline on the Personalized Medicine Journey of Protein
  • Figure 18: Difficulties Faced in Top-Down Proteomics
  • Figure 19: Future Outlook of Nanoproteomics
  • Figure 20: North America Proteomics Market, $Billion, 2022-2034
  • Figure 21: Proteomics Literature Published in the U.S. (January 2015 to December 2024)
  • Figure 22: U.S. Proteomics Market, $Billion, 2022-2034
  • Figure 23: Proteomics Literature Published in Canada (January 2015 to December 2024)
  • Figure 24: Canada Proteomics Market, $Billion, 2022-2034
  • Figure 25: Europe Proteomics Market, $Billion, 2022-2034
  • Figure 26: Proteomics Literature Published in Canada (January 2015 to December 2024)
  • Figure 27: France Proteomics Market, $Billion, 2022-2034
  • Figure 28: Proteomics Literature Published in Italy (January 2015 to December 2024)
  • Figure 29: Italy Proteomics Market, $Billion, 2022-2034
  • Figure 30: Proteomics Literature Published in Germany (January 2015 to December 2024)
  • Figure 31: Germany Proteomics Market, $Billion, 2022-2034
  • Figure 32: Proteomics Literature Published in the U.K. (January 2015 to December 2024)
  • Figure 33: U.K. Proteomics Market, $Billion, 2022-2034
  • Figure 34: Proteomics Literature Published in Spain (January 2015 to December 2024)
  • Figure 35: Spain Proteomics Market, $Billion, 2022-2034
  • Figure 36: Rest-of-Europe Proteomics Market, $Billion, 2022-2034
  • Figure 37: Asia-Pacific Proteomics Market, $Billion, 2022-2034
  • Figure 38: Proteomics Literature Published in China (January 2015 to December 2024)
  • Figure 39: China Proteomics Market, $Billion, 2022-2034
  • Figure 40: Proteomics Literature Published in India (January 2015 to December 2024)
  • Figure 41: India Proteomics Market, $Billion, 2022-2034
  • Figure 42: Proteomics Literature Published in Australia (January 2015 to December 2024)
  • Figure 43: Australia Proteomics Market, $Billion, 2022-2034
  • Figure 44: Proteomics Literature Published in Japan (January 2015 to December 2024)
  • Figure 45: Japan Proteomics Market, $Billion, 2022-2034
  • Figure 46: Proteomics Literature Published in South Korea (January 2015 to December 2024)
  • Figure 47: South Korea Proteomics Market, $Billion, 2022-2034
  • Figure 48: Rest-of-Asia-Pacific Proteomics Market, $Billion, 2022-2034
  • Figure 49: Latin America Proteomics Market, $Billion, 2022-2034
  • Figure 50: Proteomics Literature Published in Brazil (January 2015 to December 2024)
  • Figure 51: Brazil Proteomics Market, $Billion, 2022-2034
  • Figure 52: Proteomics Literature Published in Mexico (January 2015 to December 2024)
  • Figure 53: Mexico Proteomics Market, $Billion, 2022-2034
  • Figure 54: Rest-of-Latin America Proteomics Market, $Billion, 2022-2034
  • Figure 55: Middle East and Africa Market, $Billion, 2022-2034
  • Figure 56: Illustration of NGS in Proteomics
  • Figure 57: Next Generation Based Proteomics Literature Published (January 2015 to December 2024)
  • Figure 58: Global NGS in Proteomics Market Size, $Million, 2022-2034
  • Figure 59: Corporate Strategies, January 2022-December 2024
  • Figure 60: Acquisitions (by Company), January 2022-December 2024
  • Figure 61: New Offerings Share (by Company), January 2022-December 2024
  • Figure 62: Data Triangulation
  • Figure 63: Top-Down and Bottom-Up Approach
  • Figure 64: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Opportunities across Regions
  • Table 3: The Diversified Exposure of Proteomics
  • Table 4: Comparative Analysis of Proteomics: Advantages and Disadvantages Over Other Omics Approaches
  • Table 5: Introduction to Proteomics Techniques: Principles, Advantages, and Limitations
  • Table 6: Comparison of Existing and Emerging Paradigms in Proteomics Technologies
  • Table 7: Proteomics Market Trend Analysis
  • Table 8: Some of the Partnerships and Collaborations in the Global Proteomics Market
  • Table 9: List of Molecular Targets Identified with Proteomics
  • Table 10: Global Cancer Cases Expected Between 2020 and 2040
  • Table 11: Global Proteomics Market, Regulatory Approvals, and New Offerings
  • Table 12: Cancer Biomarkers Discovered by Proteomics and its Applications in Personalized Medicine
  • Table 13: Global Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 14: Global Proteomics Market (by Product), $Billion, 2022-2034
  • Table 15: Global Proteomics Market (by Instruments), $Billion, 2022-2034
  • Table 16: Global Proteomics Market (by Application), $Billion, 2022-2034
  • Table 17: Global Proteomics Market (by Clinical Diagnostics), $Billion, 2022-2034
  • Table 18: Global Proteomics Market (by End User), $Billion, 2022-2034
  • Table 19: Global Proteomics Market (by Region), $Billion, 2022-2034
  • Table 20: North America Proteomics Market (by Application), $Billion, 2022-2034
  • Table 21: North America Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 22: North America Proteomics Market (by Product), $Billion, 2022-2034
  • Table 23: U.S. Proteomics Market (by Application), $Billion, 2022-2034
  • Table 24: U.S. Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 25: U.S. Proteomics Market (by Product), $Billion, 2022-2034
  • Table 26: Canada Proteomics Market (by Application), $Billion, 2022-2034
  • Table 27: Canada Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 28: Canada Proteomics Market (by Product), $Billion, 2022-2034
  • Table 29: Europe Proteomics Market (by Application), $Billion, 2022-2034
  • Table 30: Europe Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 31: Europe Proteomics Market (by Product), $Billion, 2022-2034
  • Table 32: France Proteomics Market (by Application), $Billion, 2022-2034
  • Table 33: France Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 34: France Proteomics Market (by Product), $Billion, 2022-2034
  • Table 35: Italy Proteomics Market (by Application), $Billion, 2022-2034
  • Table 36: Italy Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 37: Italy Proteomics Market (by Product), $Billion, 2022-2034
  • Table 38: Germany Proteomics Market (by Application), $Billion, 2022-2034
  • Table 39: Germany Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 40: Germany Proteomics Market (by Product), $Billion, 2022-2034
  • Table 41: U.K. Proteomics Market (by Application), $Billion, 2022-2034
  • Table 42: U.K. Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 43: U.K. Proteomics Market (by Product), $Billion, 2022-2034
  • Table 44: Spain Proteomics Market (by Application), $Billion, 2022-2034
  • Table 45: Spain Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 46: Spain Proteomics Market (by Product), $Billion, 2022-2034
  • Table 47: Rest-of-Europe Proteomics Market (by Application), $Billion, 2022-2034
  • Table 48: Rest-of-Europe Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 49: Rest-of-Europe Proteomics Market (by Product), $Billion, 2022-2034
  • Table 50: Asia-Pacific Proteomics Market (by Application), $Billion, 2022-2034
  • Table 51: Asia-Pacific Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 52: Asia-Pacific Proteomics Market (by Product), $Billion, 2022-2034
  • Table 53: China Proteomics Market (by Application), $Billion, 2022-2034
  • Table 54: China Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 55: China Proteomics Market (by Product), $Billion, 2022-2034
  • Table 56: India Proteomics Market (by Application), $Billion, 2022-2034
  • Table 57: India Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 58: India Proteomics Market (by Product), $Billion, 2022-2034
  • Table 59: Australia Proteomics Market (by Application), $Billion, 2022-2034
  • Table 60: Australia Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 61: Australia Proteomics Market (by Product), $Billion, 2022-2034
  • Table 62: Japan Proteomics Market (by Application), $Billion, 2022-2034
  • Table 63: Japan Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 64: Japan Proteomics Market (by Product), $Billion, 2022-2034
  • Table 65: South Korea Proteomics Market (by Application), $Billion, 2022-2034
  • Table 66: South Korea Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 67: South Korea Proteomics Market (by Product), $Billion, 2022-2034
  • Table 68: Rest-of-Asia-Pacific Proteomics Market (by Application), $Billion, 2022-2034
  • Table 69: Rest-of-Asia-Pacific Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 70: Rest-of-Asia-Pacific Proteomics Market (by Product), $Billion, 2022-2034
  • Table 71: Latin America Proteomics Market (by Application), $Billion, 2022-2034
  • Table 72: Latin America Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 73: Latin America Proteomics Market (by Product), $Billion, 2022-2034
  • Table 74: Brazil Proteomics Market (by Application), $Billion, 2022-2034
  • Table 75: Brazil Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 76: Brazil Proteomics Market (by Product), $Billion, 2022-2034
  • Table 77: Mexico Proteomics Market (by Application), $Billion, 2022-2034
  • Table 78: Mexico Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 79: Mexico Proteomics Market (by Product), $Billion, 2022-2034
  • Table 80: Rest-of-Latin America Proteomics Market (by Application), $Billion, 2022-2034
  • Table 81: Rest-of-Latin America Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 82: Rest-of-Latin America Proteomics Market (by Product), $Billion, 2022-2034
  • Table 83: Middle East and Africa Proteomics Market (by Application), $Billion, 2022-2034
  • Table 84: Middle East and Africa Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 85: Middle East and Africa Proteomics Market (by Product), $Billion, 2022-2034
  • Table 86: Global NGS in Proteomics Market (by Application), $Million, 2022-2034
  • Table 87: Global NGS in Proteomics Market (by End User), $Million, 2022-2034
  • Table 88: Partnerships, Alliances, and Business Expansions (by Company), January 2022-December 2024